JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 17, 2003; DOI: 10.1124/jpet.103.057083


0022-3565/04/3081-221-227$20.00
JPET 308:221-227, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.057083v1
308/1/221    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vortherms, T. A.
Right arrow Articles by Watts, V. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vortherms, T. A.
Right arrow Articles by Watts, V. J.

NEUROPHARMACOLOGY

Sensitization of Neuronal A2A Adenosine Receptors after Persistent D2 Dopamine Receptor Activation

Timothy A. Vortherms, and Val J. Watts

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana

Acute activation of G{alpha}i/o-coupled D2 dopamine receptors inhibits A2A adenosine receptor stimulation of adenylate cyclase. This antagonistic interaction between D2 dopamine and A2A adenosine receptors has been well documented; however, the effects of persistent activation of D2 dopamine receptors on subsequent A2A adenosine receptor signaling have not been explored. The present study investigated the effects of short-term (3-h) and long-term (18-h) activation of D2L dopamine receptors on subsequent A2A adenosine receptor stimulation of adenylate cyclase in CAD-D2L and NS20Y-D2L neuroblastoma cells. Short- and long-term activation of D2L dopamine receptors markedly increased 5'-N-methylcarboxamidoadenosine (MECA)-stimulated cyclic AMP accumulation 1.4-fold and 1.7-fold, respectively. D2L receptor-induced sensitization of A2A-stimulated cyclic AMP accumulation was blocked by the D2 antagonist spiperone and pertussis toxin pretreatment. In addition, persistent activation of A2A adenosine receptors resulted in 50% desensitization of subsequent MECA-stimulated cyclic AMP accumulation; however, MECA-induced desensitization of A2A adenosine receptors did not prevent completely quinpirole-induced sensitization of adenylate cyclase. These studies revealed a novel mode of regulation between D2L dopamine and A2A adenosine receptors and suggest a cooperative interaction in the regulation of cyclic AMP signaling.


Received July 16, 2003; accepted September 17, 2003.

Address correspondence to: Dr. Val J. Watts, Medicinal Chemistry and Molecular Pharmacology, Purdue University, 575 Stadium Mall Dr., RHPH 224A, West Lafayette, IN 47907. E-mail: wattsv{at}pharmacy.purdue.edu




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
P.-A. Vidi, B. R. Chemel, C.-D. Hu, and V. J. Watts
Ligand-Dependent Oligomerization of Dopamine D2 and Adenosine A2A Receptors in Living Neuronal Cells
Mol. Pharmacol., September 1, 2008; 74(3): 544 - 551.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. A. Vortherms, C. H. Nguyen, C. H. Berlot, and V. J. Watts
Using Molecular Tools to Dissect the Role of G{alpha}s in Sensitization of AC1
Mol. Pharmacol., December 1, 2004; 66(6): 1617 - 1624.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.